The Australian Pharmaceutical Market  

Australia’s population of over 24 million is well served by a buoyant and diversified healthcare sector. 

IMS ranks Australia as the 12th largest market globally.(Medicines Australia 2015). 

Australian operates a government subsidised Pharmaceutical Benefits Scheme (PBS) where patient’s co pay for the cost of their prescriptions. The PBS operate a list of medications and approved suppliers which fall into the scheme generating the industry some $12 billion AUD in sales annually.

​

Products that are manufactured to target the EU and USA markets maybe able to be supplied to the Australian market.